Back to School: How biopharma can reboot drug development. Access exclusive analysis here
In the ATLAS Small Vessel study, Taxus Liberte showed superiority to BMS (45.6% vs. 32.1%;
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury